Cleared Traditional

K121576 - IMMULITE 2000 ANTI-CCP IGG ASSAY (FDA 510(k) Clearance)

Apr 2013
Decision
309d
Days
Class 2
Risk

K121576 is an FDA 510(k) clearance for the IMMULITE 2000 ANTI-CCP IGG ASSAY. This device is classified as a Antibodies, Anti-cyclic Citrullinated Peptide (ccp) (Class II - Special Controls, product code NHX).

Submitted by Siemens Healthcare Diagnostics, Inc. (Tarrytown, US). The FDA issued a Cleared decision on April 4, 2013, 309 days after receiving the submission on May 30, 2012.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5775. The Device Is Used For The Detection Of Anti-cyclic Citrullinated Peptide (ccp) Antibodies In Human Serum Or Plasma As An Aid In The Diagnosis Of Rheumatoid Arthritis..

Submission Details

510(k) Number K121576 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 2012
Decision Date April 04, 2013
Days to Decision 309 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code NHX — Antibodies, Anti-cyclic Citrullinated Peptide (ccp)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5775
Definition The Device Is Used For The Detection Of Anti-cyclic Citrullinated Peptide (ccp) Antibodies In Human Serum Or Plasma As An Aid In The Diagnosis Of Rheumatoid Arthritis.